Safety, Tolerability, and Efficacy of RLS103 in a Clinical Model of Photosensitive Epilepsy

NCT05678881 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of enrollment

Conditions

Epilepsy

Interventions

DRUG: High dose RLS103
DRUG: placebo inhaled powder
DRUG: Low dose RLS103

Sponsor

Receptor Life Sciences

Collaborators

[object Object]